Search

Search Constraints

You searched for: Author/Creator Brunstein, Flavia

Search Results

1. [O2–17–03]: A PHASE I STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF RO7105705 IN HEALTHY VOLUNTEERS AND PATIENTS WITH MILD‐TO‐MODERATE AD. (1st July 2017)

2. A Phase 1 study of GDC‐0134, a dual leucine zipper kinase inhibitor, in ALS. Issue 1 (10th January 2022)

3. ABBY: A phase 2 randomized trial of crenezumab in mild to moderate Alzheimer disease. (22nd May 2018)

4. O4‐11‐06: A RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CRENEZUMAB IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE. (1st July 2014)